Genetic manipulation of primate embryonic and hematopoietic stem cells with simian lentivirus vectors.
During the past several years, many articles have described how human embryonic stem (ES) cells and adult hematopoietic stem cells (HSCs) can differentiate into cardiac muscle, blood vessels, and various other types of cells. The articles raised the expectation that these stem cells may become useful for the treatment of a variety of diseases, including cardiovascular diseases. Genetic manipulation of ES cells and HSCs would be important for such future applications of the cells. Until now, retroviral vectors have been used primarily for stable expression of transgenes in murine ES cells and HSCs. Because murine models may not predict reliably the biology of ES cells and HSCs in humans, we have utilized primate ES cells and HSCs as targets of gene transfer. We have shown that primate ES cells and HSCs can be transduced efficiently with lentiviral vectors derived from the simian immunodeficiency virus, and that the high transgene expression persists without transcriptional silencing. This highly efficient gene transfer method allows for safe and faithful gene delivery to primate ES cells and HSCs to test potential research and therapeutic applications.
Hanazono
Yutaka
Y
Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Kawachi, Tochigi, Japan. hanazono@jichi.ac.jp
Asano
Takayuki
T
Ueda
Yasuji
Y
Ozawa
Keiya
K
D000818:Animals; D002318:Cardiovascular Diseases / Q000235:genetics / Q000628:therapy; D002454:Cell Differentiation / Q000235:genetics; D004622:Embryo, Mammalian / Q000166:cytology*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics*; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D006801:Humans; D015302:Simian Immunodeficiency Virus / Q000235:genetics*